Created On: 2020-07-15
Record Count: 5
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 1335
The Licensee was granted rights to practice the invention as well as further develop antibodies to treat Pa.
KB001 is a first generation, anti-Pseudomonas aeruginosa (Pa) type III secretion system (TTSS) antibody, for use in patients with cystic fibrosis (CF).
IPSCIO Record ID: 28884
IPSCIO Record ID: 1334
The Licensee is solely responsible for the costs and development of KB001-A for pneumonia prevention and other hospital indications. We are currently planning a Phase 2 trial in CF.
IPSCIO Record ID: 118195
IPSCIO Record ID: 28236